InSphero is the pioneer of industrial-grade, 3D-cell-based assay solutions and scaffold-free 3D organ-on-a-chip technology. Through partnerships, InSphero supports pharmaceutical and biotechnology researchers in successful decision-making by accurately rebuilding the human physiology in vitro. Its robust and precisely engineered suite of 3D InSight™ human tissue platforms are used by major pharmaceutical companies worldwide to increase efficiency in drug discovery and safety testing. The company specializes in liver toxicology, metabolic diseases (e.g., T1 & T2 diabetes and NAFLD & NASH liver disease), and oncology (with a focus on immuno-oncology and PDX models).
News
Milestones/News
Documents
Videos and Presentations
120 sec introduction to cancer applications of InSphero's 3D InSight™ Tumor Microtissues
90 sec introduction to InSphero's 3D InSight™ Liver Microtissues
InSphero at IFJ
InSphero company video